האיחוד האירופי -
אנגלית -
EMA (European Medicines Agency)
beyfortus
astrazeneca ab - nirsevimab - immune sera and immunoglobulins, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season.beyfortus should be used in accordance with official recommendations.
קנדה -
אנגלית -
Health Canada
beyfortus solution
astrazeneca canada inc - nirsevimab - solution - 50mg - nirsevimab 50mg
קנדה -
אנגלית -
Health Canada
beyfortus solution
astrazeneca canada inc - nirsevimab - solution - 100mg - nirsevimab 100mg